November 2025 Provider News
Date: 11/28/25
In this issue:
- General Updates - WA Telebuprenorphine Hotline helping to address OUD for ages 13+ is expanding statewide in 2026, Washington State Health Care Authority (HCA) is offering free substance use disorder (SUD) family-led education sessions designed for parents and caregivers
- Quality - Cervical Cancer screening, Asthma and 90 day medication refill, Oral Health training, Telehealth, Influenza vaccine recommendation
- Tribal - Coordinated Care 2026 AEP product highlight webinar
- Clinical & Payment Policies and Prior Authorization Updates - Evolent Cardiovascular program, Envolve Vision
- Wellcare - CMS Prior auth changes eff 01/01/26, Wellcare Medical Clinical Policy update
- Training/Education - Multi-payer Collaborative Primary Care Provider Learning Cohort, Autism Center of Excellence (COE) Certification Training, Evolent training sessions, Self Neglect Summit
- Pharmacy Updates - January 1, 2026 Preferred Drug List Changes, Pharmacy Clinical Policy Updates
______________________________________________________________________________________
General Updates
WA Telebuprenorphine Hotline helping to address OUD for ages 13+ is expanding statewide in 2026
Washington State Health Care Authority (HCA) is offering free substance use disorder (SUD) family-led education sessions designed for parents and caregivers.
Families affected by SUD don’t have to face it alone. In this 8-week series, you’ll:
- Learn practical, evidence-based skills grounded in the CRAFT model
- Improve communication and reduce conflict
- Navigate Washington’s behavioral health systems
Morning and evening options available. Certificate of Completion provided.
Learn more and register today.
______________________________________________________________________________________
Quality
Medicaid Quality
Cervical Cancer Screening
Cervical Cancer Screening (CCS-E) - NCQA
The goal for CCS is to assess the following for your patients:
- Women 21 - 64 years of age who have had cervical cytology performed within last 3 yrs.•Women 30 - 64 years of age who had cervical high risk human papillomavirus testing performed within the last 5 yrs.
- Women 30 - 64 years of age who had cervical/high risk human papillomavirus cotesting within the last 5 yrs.
Asthma and 90 Day Medication Refills
Asthma is a treatable, manageable, condition that affects more than 25 million people in the United States. Managing this condition with appropriate medications could save the U.S. billions of dollars in medical costs.1 The prevalence and cost of asthma have increased over the past decade, demonstrating the need for better access to care and medication. Appropriate medication management for patients with asthma could reduce the need for rescue medication—as well as the costs associated with ER visits, inpatient admissions and missed days of work or school.
Moving members with asthma prescriptions to 90-day medication refills may increase their maintenance medication adherence.
Oral Health Training for Healthcare Professionals
Smiles for Life is a comprehensive oral health curriculum for healthcare professionals and health educators. This American Dental Association endorsed curriculum is designed to enhance the role of primary care clinicians in the promotion of oral health for all age groups. This curriculum includes oral health training for all ages and offers free CME to healthcare providers.
Telehealth
Telehealth increases access to physicians and specialists to help patients receive the right care, at the right place, at the right time.
For providers | Telehealth.HHS.gov
TELEHEALTH FOR PROVIDERS: WHAT YOU NEED TO KNOW (PDF)
Influenza Vaccine Recommendation
It is important to remind members to get vaccinated and follow up to ensure it has been received. Repeat recommendations for those who are unvaccinated and answer any questions they may have. Strong professional recommendation plays a critical role in our members receiving their vaccination.
Talking About Influenza Vaccine Recommendation | Influenza (Flu) | CDC
Wellcare Quality
Influenza Vaccine Recommendation
It is important to remind members to get vaccinated and follow up to ensure it has been received. Repeat recommendations for those who are unvaccinated and answer any questions they may have. Strong professional recommendation plays a critical role in our members receiving their vaccination.
Talking About Influenza Vaccine Recommendation | Influenza (Flu) | CDC
_______________________________________________________________________________________
Tribal
Tribal Partners-Coordinated Care 2026 AEP product highlight Webinar
Please join us for the Coordinated Care 2026 AEP Product Highlights Webinar.
This session will provide an overview of Coordinated Care’s plan offerings and key updates for the upcoming enrollment periods. Topics will include Ambetter, Medicaid, and Wellcare plans for 2026, with a focus on helping providers stay informed and prepared.
For any questions, please email the IHCP team: IndianHealthCareProviderAssistance@coordinatedcarehealth.com
_______________________________________________________________________________________
Clinical & Payment Policies and Prior Authorization Updates
Clinical Policy Updates
With the start of the new Evolent Cardiovascular program, the following policies will be effective on January 1, 2026. You will find the policies on Evolent’s public facing website now, or on the Evolent landing page found at the link on our Prior Authorization page after 1/1/26. Please note, this program does not apply to children under the age of 18.
ECG_7252 | Evolent - Ambulatory Rhythm Monitoring |
ECG_7254 | Evolent - Coronary Artery Bypass Graft |
ECG_7255 | Evolent - Aortic Valve Replacement |
ECG_7258 | Evolent - Device Interrogation and Programming |
ECG_7261 | Evolent - Device (AICD, CRT and/or Pacemaker) Battery Replacement |
ECG_7262 | Evolent - Diagnostic Electrophysiologic Testing |
ECG_7263 | Evolent - Cardiac Resynchronization Therapy |
ECG_7264 | Evolent - Renal Angiography and Intervention |
ECG_7266 | Evolent - Carotid Artery Stenting |
ECG_7268 | Evolent - Carotid Endarterectomy |
ECG_7269 | Evolent - Catheter Based Carotid & Brachiocephalic Arteriography, Venography & Intervention |
ECG_7282 | Evolent - Atrial Fibrillation Ablation |
ECG_7283 | Evolent - Abdominal Aortography w Bilateral Iliofemoral Lower Extremity Runoff |
ECG_7284 | Evolent - Catheter Ablation of Reentrant or Focal Tachydysrhythmias |
ECG_7286 | Evolent - Endomyocardial Biopsy |
ECG_7287 | Evolent - Endovascular Femoropopliteal Interventions |
ECG_7288 | Evolent - Endovascular Aortoiliac Interventions |
ECG_7289 | Evolent - Endovascular Infrapopliteal (Tibioperoneal) Interventions |
ECG_7290 | Evolent - Treatment of Varicose Veins |
ECG_7292 | Evolent - Infra-inguinal Open Arterial Vascular Surgery |
ECG_7295 | Evolent - Hearth Catheterization |
ECG_7299 | Evolent - Hemodialysis Access Creation |
ECG_7301 | Evolent - Implantable Cardioverter Defibrillator |
ECG_7302 | Evolent - Percutaneous Coronary Interventions |
ECG_7303 | Evolent - Interventions for Adults with Congenital Heart Defects |
ECG_7305 | Evolent - Introduction of Inferior Vena Cava Filter Device |
ECG_7310 | Evolent - Mitral Valve Surgery |
ECG_7315 | Evolent - Pacemaker Insertion |
ECG_7319 | Evolent - Percutaneous Iliocaval Interventions |
ECG_7320 | Evolent - Percutaneous Left Atrial Appendage Closure |
ECG_7327 | Evolent - Standalone Right Heart Catheterization |
ECG_7334 | Evolent - Transcatheter Aortic Valve Replacement (TAVR) |
ECG_7335 | Evolent - Transcatheter Edge to Edge Repair (TEER) of Mitral Valve |
ECG_7338 | Evolent - Tricuspid Valve Surgery |
ECG_7339 | Evolent - Ultrasound-Guided Vascular Access |
ECG_7341 | Evolent - Venogram Invasive Vein Mapping |
ECG_7345 | Evolent - Wireless Pulmonary Artery Pressure Device Placement and Monitoring |
Envolve Vision has announced annual updates to their policies. These changes are effective for Apple Health and Ambetter on January 1, 2026. You will find the policies on their website. You can find a link to Envolve Vision’s website on our Prior Authorization page.
The following policies were previously announced as revised effective on the date noted. You will find the policies posted on the policy site.
Policy Number | Policy Title | Effective Date | Line of Business |
WA.CP.MP.54 | Hospice Services | 12/1/25 | Apple Health |
CP.MP.49 | Physical, Occupational and Speech Therapy Services | 12/1/25 | Apple Health & Ambetter |
WA.CP.MP.185 | Skin and Soft Tissue Substitutes | 12/1/25 | Apple Health |
CP.MP.185 | Skin and Soft Tissue Substitutes for Chronic Wounds | 12/1/25 | Ambetter |
WA.CP.MP.527 | Vitamin D Testing | 1/1/26 | Apple Health & Ambetter |
CP.MP.93 | Bone-anchored hearing aid | 1/1/26 | Apple Health & Ambetter |
CG.CP.MP.01 | Infection Disease: Respiratory Lab Testing | 1/1/26 | Apple Health & Ambetter |
CG.CP.MP.02 | Infectious Disease: Multisystems Lab Testing | 1/1/26 | Apple Health & Ambetter |
CG.CP.MP.03 | Infectious Dz Dermatologic Lab Testing | 1/1/26 | Apple Health & Ambetter |
CG.CP.MP.04 | Infectious Dz Gastroenterologic Lab Testing | 1/1/26 | Apple Health & Ambetter |
CG.CP.MP.05 | ID Primary Care Preventive Lab Testing | 1/1/26 | Apple Health & Ambetter |
CG.CP.MP.06 | ID Vector-Borne and Tropical Dz Lab Testing | 1/1/26 | Apple Health & Ambetter |
CG.PP.551A | Concert Genetic and Molecular Testing Payment Policy | 1/1/26 | Apple Health & Ambetter |
CG.CC.PP.01 | Concert Lab Payment Policy | 1/1/26 | Apple Health & Ambetter |
CP.MP.107 | DME | 2/1/26 | Apple Health & Ambetter |
CP.MP.202 | Orthognathic Surgery | 2/1/26 | Apple Health & Ambetter |
The following policies were previously announced as being archived on the dates noted.
Policy Number | Policy Title | Effective Date | Line of Business |
WA.HIM.CP.MP.92 | Acupuncture | 12/31/25 | Ambetter |
CC.PP.018 | Inpatient Only Procedures | 12/31/25 | Apple Health |
MP.PP.018 | Inpatient Only Procedures | 12/31/25 | Ambetter |
WA.CP.MP.516 | Carotid Artery Stenting | 12/31/25 | Apple Health & Ambetter |
WA.CP.MP.525 | Catheter Ablation for SVTA | 12/31/25 | Apple Health & Ambetter |
WA.CP.MP.522 | Varicose Vein Treatment | 12/31/25 | Apple Health & Ambetter |
WA.CP.MP.513 | Cardiac Stents | 12/31/25 | Apple Health & Ambetter |
Prior Authorization Updates
The following services will require prior authorization effective January 1, 2026:
Line of Business | Code | Description |
Apple Health | 69714 | Implantation, osseo-integrated implant, skull; with percutaneous attachment to external speech processor |
Apple Health | 69729 | Implantation, osseo-integrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside of the mastoid and resulting in removal of greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex |
With the implementation of the Evolent Interventional Cardiology program for both Ambetter and Apple Health on January 1, 2026, the following services will require prior authorization from Evolent as of January 1:
Evolent Interventional Cardiology Program Prior Authorization Requirements | |
Code | Description |
33202 | Insertion of epicardial electrode(s); open incision (eg, thoracotomy, median sternotomy, subxiphoid approach) |
33203 | Insertion of epicardial electrode(s); endoscopic approach (eg, thoracoscopy, pericardioscopy) |
33206 | Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); atrial |
33207 | Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); ventricular |
33208 | Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); atrial and ventricular |
33210 | Insertion or replacement of temporary transvenous single chamber cardiac electrode or pacemaker catheter (separate procedure) |
33211 | Insertion or replacement of temporary transvenous dual chamber pacing electrodes (separate procedure) |
33212 | Insertion of pacemaker pulse generator only; with existing single lead |
33213 | Insertion of pacemaker pulse generator only; with existing dual leads |
33214 | Upgrade of implanted pacemaker system, conversion of single chamber system to dual chamber system (includes removal of previously placed pulse generator, testing of existing lead, insertion of new lead, insertion of new pulse generator) |
33215 | Repositioning of previously implanted transvenous pacemaker or implantable defibrillator (right atrial or right ventricular) electrode |
33216 | Insertion of a single transvenous electrode, permanent pacemaker or implantable defibrillator |
33217 | Insertion of 2 transvenous electrodes, permanent pacemaker or implantable defibrillator |
33218 | Repair of single transvenous electrode, permanent pacemaker or implantable defibrillator |
33220 | Repair of 2 transvenous electrodes for permanent pacemaker or implantable defibrillator |
33221 | Insertion of pacemaker pulse generator only; with existing multiple leads |
33222 | Relocation of skin pocket for pacemaker |
33223 | Relocation of skin pocket for implantable defibrillator |
33224 | Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, with attachment to previously placed pacemaker or implantable defibrillator pulse generator (including revision of pocket, removal, insertion, and/or replacement of existing generator) |
33225 | Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) (List separately in addition to code for primary procedure) |
33226 | Repositioning of previously implanted cardiac venous system (left ventricular) electrode (including removal, insertion and/or replacement of existing generator) |
33227 | Removal of Permanent Pacemaker Pulse Generator with Replacement of Pacemaker Pulse Generator; single Lead System |
33228 | Removal of Permanent Pacemaker Pulse Generator with Replacement of Pacemaker Pulse Generator; Dual Lead System |
33229 | Removal of Permanent Pacemaker Pulse Generator with Replacement of Pacemaker Pulse Generator; Multiple Lead System |
33230 | Insertion of implantable defibrillator pulse generator only; with existing dual leads |
33231 | Insertion of implantable defibrillator pulse generator only; with existing multiple leads |
33233 | Removal of permanent pacemaker pulse generator only |
33234 | Removal of transvenous pacemaker electrode(s); single lead system, atrial or ventricular |
33235 | Removal of transvenous pacemaker electrode(s); dual lead system |
33236 | Removal of permanent epicardial pacemaker and electrodes by thoracotomy; single lead system, atrial or ventricular |
33237 | Removal of permanent epicardial pacemaker and electrodes by thoracotomy; dual lead system |
33240 | Insertion of implantable defibrillator pulse generator only; with existing single lead |
33241 | Removal of implantable defibrillator pulse generator only |
33243 | Removal of single or dual chamber implantable defibrillator electrode(s); by thoracotomy |
33244 | Removal of single or dual chamber implantable defibrillator electrode(s); by transvenous extraction |
33249 | Insertion or replacement of permanent implantable defibrillator system, with transvenous lead(s), single or dual chamber |
33262 | Removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; single lead system |
33263 | Removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; dual lead system |
33264 | Removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; multiple lead system |
33270 | Insertion or replacement of permanent subcutaneous implantable defibrillator system, with subcutaneous electrode, including defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters, when performed |
33271 | Insertion of subcutaneous implantable defibrillator electrode |
33272 | Removal of subcutaneous implantable defibrillator electrode |
33273 | Repositioning of previously implanted subcutaneous implantable defibrillator electrode |
33274 | Transcatheter insertion or replacement of permanent leadless pacemaker, right ventricular, including imaging guidance (eg, fluoroscopy, venous ultrasound, ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed |
33275 | Transcatheter removal of permanent leadless pacemaker, right ventricular, including imaging guidance (eg, fluoroscopy, venous ultrasound, ventriculography, femoral venography), when performed |
33285 | Insertion, subcutaneous cardiac rhythm monitor, including programming |
33286 | Removal, subcutaneous cardiac rhythm monitor |
33289 | Transcatheter implantation of wireless pulmonary artery pressure sensor for long-term hemodynamic monitoring, including deployment and calibration of the sensor, right heart catheterization, selective pulmonary catheterization, radiological supervision and interpretation, and pulmonary artery angiography, when performed |
33340 | Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation |
33361 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; percutaneous femoral artery approach |
33362 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open femoral artery approach |
33363 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open axillary artery approach |
33364 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open iliac artery approach |
33365 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transaortic approach (eg, median sternotomy, mediastinotomy) |
33366 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transapical exposure (eg, left thoracotomy) |
33367 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with percutaneous peripheral arterial and venous cannulation (eg, femoral vessels) (List separately in addition to code for primary procedure) |
33368 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with open peripheral arterial and venous cannulation (eg, femoral, iliac, axillary vessels) (List separately in addition to code for primary procedure) |
33369 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (eg, aorta, right atrium, pulmonary artery) (List separately in addition to code for primary procedure) |
33405 | Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve |
33406 | Replacement, aortic valve, open, with cardiopulmonary bypass; with allograft valve (freehand) |
33410 | Replacement, aortic valve, open, with cardiopulmonary bypass; with stentless tissue valve |
33411 | Replacement, aortic valve; with aortic annulus enlargement, noncoronary sinus |
33412 | Replacement, aortic valve; with transventricular aortic annulus enlargement (Konno procedure) |
33413 | Replacement, aortic valve; by translocation of autologous pulmonary valve with allograft replacement of pulmonary valve (Ross procedure) |
33418 | Transcatheter mitral valve repair, percutaneous approach, including transseptal puncture when performed; initial prosthesis |
33419 | Transcatheter mitral valve repair, percutaneous approach, including transseptal puncture when performed; additional prosthesis(es) during same session (List separately in addition to code for primary procedure) |
33425 | Valvuloplasty, mitral valve, with cardiopulmonary bypass; |
33426 | Valvuloplasty, mitral valve, with cardiopulmonary bypass; with prosthetic ring |
33427 | Valvuloplasty, mitral valve, with cardiopulmonary bypass; radical reconstruction, with or without ring |
33430 | Replacement, mitral valve, with cardiopulmonary bypass |
33440 | Replacement, aortic valve; by translocation of autologous pulmonary valve and transventricular aortic annulus enlargement of the left ventricular outflow tract with valved conduit replacement of pulmonary valve (Ross-Konno procedure) |
33465 | Replacement, Tricuspid Valve, with Cardiopulmonary Bypass |
33475 | Replacement, Pulmonary Valve |
33477 | Transcatheter pulmonary valve implantation, percutaneous approach, including pre-stenting of the valve delivery site, when performed |
33510 | Coronary artery bypass, vein only; single coronary venous graft |
33511 | Coronary artery bypass, vein only; 2 coronary venous grafts |
33512 | Coronary artery bypass, vein only; 3 coronary venous grafts |
33513 | Coronary artery bypass, vein only; 4 coronary venous grafts |
33514 | Coronary artery bypass, vein only; 5 coronary venous grafts |
33516 | Coronary artery bypass, vein only; 6 or more coronary venous grafts |
33517 | Coronary artery bypass, using venous graft(s) and arterial graft(s); single vein graft (List separately in addition to code for primary procedure) |
33518 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 2 venous grafts (List separately in addition to code for primary procedure) |
33519 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 3 venous grafts (List separately in addition to code for primary procedure) |
33521 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 4 venous grafts (List separately in addition to code for primary procedure) |
33522 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 5 venous grafts (List separately in addition to code for primary procedure) |
33523 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 6 or more venous grafts (List separately in addition to code for primary procedure) |
33530 | Reoperation, coronary artery bypass procedure or valve procedure, more than 1 month after original operation (List separately in addition to code for primary procedure) |
33533 | Coronary artery bypass, using arterial graft(s); single arterial graft |
33534 | Coronary artery bypass, using arterial graft(s); 2 coronary arterial grafts |
33535 | Coronary artery bypass, using arterial graft(s); 3 coronary arterial grafts |
33536 | Coronary artery bypass, using arterial graft(s); 4 or more coronary arterial grafts |
33572 | Coronary endarterectomy, open, any method, of left anterior descending, circumflex, or right coronary artery performed in conjunction with coronary artery bypass graft procedure, each vessel (List separately in addition to primary procedure) |
33641 | Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch |
33768 | Anastomosis, cavopulmonary, second superior vena cava (List separately in addition to primary procedure) |
33820 | Repair of patent ductus arteriosus; by ligation |
33840 | Excision of coarctation of aorta, with or without associated patent ductus arteriosus; with direct anastomosis |
33900 | Percutaneous pulmonary artery revascularization by stent placement, initial; normal native connections, unilateral |
33901 | Percutaneous pulmonary artery revascularization by stent placement, initial; normal native connections, bilateral |
33902 | Percutaneous pulmonary artery revascularization by stent placement, initial; abnormal connections, unilateral |
33903 | Percutaneous pulmonary artery revascularization by stent placement, initial; abnormal connections, bilateral |
33904 | Percutaneous pulmonary artery revascularization by stent placement, each additional vessel or separate lesion, normal or abnormal connections (List separately in addition to code for primary procedure) |
33917 | Repair of pulmonary artery stenosis by reconstruction with patch or graft |
33924 | Ligation and takedown of a systemic-to-pulmonary artery shunt, performed in conjunction with a congenital heart procedure (List separately in addition to code for primary procedure) |
35001 | Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm and associated occlusive disease, carotid, subclavian artery, by neck incision |
35011 | Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm and associated occlusive disease, axillary-brachial artery, by arm incision |
35141 | Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, common femoral artery (profunda femoris, superficial femoral) |
35151 | Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, popliteal artery |
35301 | Thromboendarterectomy, including patch graft, if performed; carotid, vertebral, subclavian, by neck incision |
35302 | Thromboendarterectomy, including patch graft, if performed; superficial femoral artery |
35303 | Thromboendarterectomy, including patch graft, if performed; popliteal artery |
35304 | Thromboendarterectomy, including patch graft, if performed; tibioperoneal trunk artery |
35305 | Thromboendarterectomy, including patch graft, if performed; tibial or peroneal artery, initial vessel |
35306 | Thromboendarterectomy, including patch graft, if performed; each additional tibial or peroneal artery (List separately in addition to code for primary procedure) |
35351 | Thromboendarterectomy, including patch graft, if performed; iliac |
35355 | Thromboendarterectomy, including patch graft, if performed; iliofemoral |
35371 | Thromboendarterectomy, including patch graft, if performed; common femoral |
35372 | Thromboendarterectomy, including patch graft, if performed; deep (profunda) femoral |
35390 | Reoperation, carotid, thromboendarterectomy, more than 1 month after original operation (List separately in addition to code for primary procedure) |
35400 | Angioscopy (noncoronary vessels or grafts) during therapeutic intervention (List separately in addition to code for primary procedure) |
35500 | Harvest of upper extremity vein, 1 segment, for lower extremity or coronary artery bypass procedure (List separately in addition to code for primary procedure) |
35556 | Bypass graft, with vein; femoral-popliteal |
35558 | Bypass graft, with vein; femoral-femoral |
35566 | Bypass graft, with vein; femoral-anterior tibial, posterior tibial, peroneal artery or other distal vessels |
35571 | Bypass graft, with vein; popliteal-tibial, -peroneal artery or other distal vessels |
35572 | Harvest of femoropopliteal vein, 1 segment, for vascular reconstruction procedure (eg, aortic, vena caval, coronary, peripheral artery) (List separately in addition to code for primary procedure) |
35583 | In-situ vein bypass; femoral-popliteal |
35585 | In-situ vein bypass; femoral-anterior tibial, posterior tibial, or peroneal artery |
35587 | In-situ vein bypass; popliteal-tibial, peroneal |
35600 | Harvest of upper extremity artery, 1 segment, for coronary artery bypass procedure, open |
35621 | Bypass graft, with other than vein; axillary-femoral |
35646 | Bypass graft, with other than vein; aortobifemoral |
35654 | Bypass graft, with other than vein; axillary-femoral-femoral |
35656 | Bypass graft, with other than vein; femoral-popliteal |
35661 | Bypass graft, with other than vein; femoral-femoral |
35665 | Bypass graft, with other than vein; Iliofemoral |
35666 | Bypass graft, with other than vein; femoral-anterior tibial, posterior tibial, or peroneal artery |
35671 | Bypass graft, with other than vein; popliteal-tibial or -peroneal artery |
35700 | Reoperation, femoral-popliteal or femoral (popliteal)-anterior tibial, posterior tibial, peroneal artery, or other distal vessels, more than 1 month after original operation (List separately in addition to code for primary procedure) |
35881 | Revision, lower extremity arterial bypass, without thrombectomy, open; with segmental vein interposition |
35883 | Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with nonautogenous patch graft (eg, Dacron, ePTFE, bovine pericardium) |
35884 | Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft |
36005 | Injection procedure for extremity venography (including introduction of needle or intracatheter) |
36140 | Introduction of needle or intracatheter, upper or lower extremity artery |
36200 | Introduction of catheter, aorta |
36215 | Selective catheter placement, arterial system; each first order thoracic or brachiocephalic branch, within a vascular family |
36216 | Selective catheter placement, arterial system; initial second order thoracic or brachiocephalic branch, within a vascular family |
36217 | Selective catheter placement, arterial system; initial third order or more selective thoracic or brachiocephalic branch, within a vascular family |
36218 | Selective catheter placement, arterial system; additional second order, third order, and beyond, thoracic or brachiocephalic branch, within a vascular family (List in addition to code for initial second or third order vessel as appropriate) |
36221 | Non-selective catheter placement, thoracic aorta, with angiography of the extracranial carotid, vertebral, and/or intracranial vessels, unilateral or bilateral, and all associated radiological supervision and interpretation, includes angiography of the cervicocerebral arch, when performed |
36245 | Selective catheter placement, arterial system; each first order abdominal, pelvic, or lower extremity artery branch, within a vascular family |
36246 | Selective catheter placement, arterial system; initial second order abdominal, pelvic, or lower extremity artery branch, within a vascular family |
36247 | Selective catheter placement, arterial system; initial third order or more selective abdominal, pelvic, or lower extremity artery branch, within a vascular family |
36251 | Selective catheter placement (first-order), main renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; unilateral |
36252 | Selective catheter placement (first-order), main renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture and catheter placement(s), fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; bilateral |
36253 | Superselective catheter placement (one or more second order or higher renal artery branches) renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture, catheterization, fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; unilateral |
36254 | Superselective catheter placement (one or more second order or higher renal artery branches) renal artery and any accessory renal artery(s) for renal angiography, including arterial puncture, catheterization, fluoroscopy, contrast injection(s), image postprocessing, permanent recording of images, and radiological supervision and interpretation, including pressure gradient measurements when performed, and flush aortogram when performed; bilateral |
36465 | Injection of non-compounded foam sclerosant with ultrasound compression maneuvers to guide dispersion of the injectate, inclusive of all imaging guidance and monitoring; single incompetent extremity truncal vein (eg, great saphenous vein, accessory saphenous vein) |
36466 | Injection of non-compounded foam sclerosant with ultrasound compression maneuvers to guide dispersion of the injectate, inclusive of all imaging guidance and monitoring; multiple incompetent truncal veins (eg, great saphenous vein, accessory saphenous vein), same leg |
36473 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated |
36474 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure) |
36475 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated |
36476 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure) |
36478 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, laser; first vein treated |
36479 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, laser; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure) |
36482 | Endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; first vein treated |
36483 | Endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure) |
36836 | Percutaneous arteriovenous fistula creation, upper extremity, single access of both the peripheral artery and peripheral vein, including fistula maturation procedures (eg, transluminal balloon angioplasty, coil embolization) when performed, including all vascular access, imaging guidance and radiologic supervision and interpretation |
36837 | Percutaneous arteriovenous fistula creation, upper extremity, separate access sites of the peripheral artery and peripheral vein, including fistula maturation procedures (eg, transluminal balloon angioplasty, coil embolization) when performed, including all vascular access, imaging guidance and radiologic supervision and interpretation |
37215 | Transcatheter placement of intravascular stent(s), cervical carotid artery, open or percutaneous, including angioplasty, when performed, and radiological supervision and interpretation; with distal embolic protection |
37220 | Revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal angioplasty |
37221 | Revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed |
37224 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal angioplasty |
37225 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with atherectomy, includes angioplasty within the same vessel, when performed |
37226 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed |
37227 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed |
37228 | Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty |
37229 | Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with atherectomy, includes angioplasty within the same vessel, when performed |
37230 | Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed |
37231 | Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed |
37232 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal angioplasty (List separately in addition to code for primary procedure) |
37233 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with atherectomy, includes angioplasty within the same vessel, when performed (List separately in addition to code for primary procedure) |
37234 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed (List separately in addition to code for primary procedure) |
37235 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed (List separately in addition to code for primary procedure) |
37236 | Transcatheter placement of an intravascular stent(s) (except lower extremity artery(s) for occlusive disease, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological supervision and interpretation and including all angioplasty within the same vessel, when performed; initial artery |
37237 | Transcatheter placement of an intravascular stent(s) (except lower extremity artery(s) for occlusive disease, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological supervision and interpretation and including all angioplasty within the same vessel, when performed; each additional artery (List separately in addition to code for primary procedure) |
37238 | Transcatheter Placement of An Intravascular Stent(S), Open or Percutaneous, including Radiological Supervision and Interpretation and including Angioplasty within the Same Vessel, when Performed; initial Vein |
37239 | Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; each additional vein (List separately in addition to code for primary procedure) |
37246 | Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; initial artery |
37247 | Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; each additional artery (List separately in addition to code for primary procedure) |
37248 | Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; initial vein |
37249 | Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; each additional vein (List separately in addition to code for primary procedure) |
37765 | Stab phlebectomy of varicose veins, 1 extremity; 10-20 stab incisions |
37766 | Stab phlebectomy of varicose veins, 1 extremity; more than 20 incisions |
4110F | Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (CABG) |
75580 | Noninvasive estimate of coronary fractional flow reserve (FFR) derived from augmentative software analysis of the data set from a coronary computed tomography angiography, with interpretation and report by a physician or other qualified health care professional |
75625 | Aortography, abdominal, by serialography, radiological supervision and interpretation |
75630 | Aortography, abdominal plus bilateral iliofemoral lower extremity, catheter, by serialography, radiological supervision and interpretation |
75710 | Angiography, extremity, unilateral, radiological supervision and interpretation |
75716 | Angiography, extremity, bilateral, radiological supervision and interpretation |
75726 | Angiography, visceral, selective or supraselective (with or without flush aortogram), radiological supervision and interpretation |
75736 | Angiography, pelvic, selective or supraselective, radiological supervision and interpretation |
76937 | Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) |
76984 | Ultrasound, intraoperative thoracic aorta (eg, epiaortic), diagnostic |
76987 | Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; including placement and manipulation of transducer, image acquisition, interpretation and report |
76988 | Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; placement, manipulation of transducer, and image acquisition only |
76989 | Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; interpretation and report only |
92920 | Percutaneous transluminal coronary angioplasty; single major coronary artery or branch |
92921 | Percutaneous transluminal coronary angioplasty; each additional branch of a major coronary artery (List separately in addition to code for primary procedure) |
92924 | Percutaneous transluminal coronary atherectomy, with coronary angioplasty when performed; single major coronary artery or branch |
92925 | Percutaneous transluminal coronary atherectomy, with coronary angioplasty when performed; each additional branch of a major coronary artery (List separately in addition to code for primary procedure) |
92928 | Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
92929 | Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (List separately in addition to code for primary procedure) |
92933 | Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch |
92934 | Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (List separately in addition to code for primary procedure) |
92937 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel |
92938 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (List separately in addition to code for primary procedure) |
92943 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; single vessel |
92944 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (List separately in addition to code for primary procedure) |
92960 | Cardioversion, elective, electrical conversion of arrhythmia; external |
92961 | Cardioversion, elective, electrical conversion of arrhythmia; internal (separate procedure) |
92972 | Percutaneous transluminal coronary lithotripsy (List separately in addition to code for primary procedure) |
92973 | Percutaneous transluminal coronary thrombectomy mechanical (List separately in addition to code for primary procedure) |
92974 | Transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy (List separately in addition to code for primary procedure) |
92978 | Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vessel (List separately in addition to code for primary procedure) |
92979 | Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; each additional vessel (List separately in addition to code for primary procedure) |
92986 | Percutaneous balloon valvuloplasty; aortic valve |
92987 | Percutaneous balloon valvuloplasty; mitral valve |
92997 | Percutaneous transluminal pulmonary artery balloon angioplasty; single vessel |
92998 | Percutaneous transluminal pulmonary artery balloon angioplasty; each additional vessel (List separately in addition to code for primary procedure) |
93292 | Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; wearable defibrillator system |
93451 | Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed |
93452 | Left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed |
93453 | Combined right and left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed |
93454 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; |
93455 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography |
93456 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization |
93457 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization |
93458 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed |
93459 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography |
93460 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed |
93461 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography |
93462 | Left heart catheterization by transseptal puncture through intact septum or by transapical puncture (List separately in addition to code for primary procedure) |
93463 | Pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed (List separately in addition to code for primary procedure) |
93464 | Physiologic exercise study (eg, bicycle or arm ergometry) including assessing hemodynamic measurements before and after (List separately in addition to code for primary procedure) |
93505 | Endomyocardial Biopsy |
93563 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective coronary angiography during congenital heart catheterization (List separately in addition to code for primary procedure) |
93564 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective opacification of aortocoronary venous or arterial bypass graft(s) (eg, aortocoronary saphenous vein, free radial artery, or free mammary artery graft) to one or more coronary arteries and in situ arterial conduits (eg, internal mammary), whether native or used for bypass to one or more coronary arteries during congenital heart catheterization, when performed (List separately in addition to code for primary procedure) |
93565 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective left ventricular or left atrial angiography (List separately in addition to code for primary procedure) |
93566 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective right ventricular or right atrial angiography (List separately in addition to code for primary procedure) |
93567 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for supravalvular aortography (List separately in addition to code for primary procedure) |
93568 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for pulmonary angiography (List separately in addition to code for primary procedure) |
93569 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary arterial angiography, unilateral (List separately in addition to code for primary procedure) |
93571 | Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary procedure) |
93572 | Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; each additional vessel (List separately in addition to code for primary procedure) |
93573 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary arterial angiography, bilateral (List separately in addition to code for primary procedure) |
93574 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary venous angiography of each distinct pulmonary vein during cardiac catheterization (List separately in addition to code for primary procedure) |
93575 | Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary angiography of major aortopulmonary collateral arteries (MAPCAs) arising off the aorta or its systemic branches, during cardiac catheterization for congenital heart defects, each distinct vessel (List separately in addition to code for primary procedure) |
93580 | Percutaneous transcatheter closure of congenital interatrial communication (ie, Fontan fenestration, atrial septal defect) with implant |
93581 | Percutaneous transcatheter closure of a congenital ventricular septal defect with implant |
93582 | Percutaneous transcatheter closure of patent ductus arteriosus |
93583 | Percutaneous Transcatheter Septal Reduction therapy (Eg, Alcohol Septal Ablation) including Temporary Pacemaker Insertion when Performed |
93590 | Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, mitral valve |
93591 | Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, aortic valve |
93592 | Percutaneous transcatheter closure of paravalvular leak; each additional occlusion device (List separately in addition to code for primary procedure) |
93609 | Intraventricular and/or intra-atrial mapping of tachycardia site(s) with catheter manipulation to record from multiple sites to identify origin of tachycardia (List separately in addition to code for primary procedure) |
93613 | Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure) |
93619 | Comprehensive electrophysiologic evaluation with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording, including insertion and repositioning of multiple electrode catheters, without induction or attempted induction of arrhythmia |
93620 | Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording |
93621 | Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with left atrial pacing and recording from coronary sinus or left atrium (List separately in addition to code for primary procedure) |
93622 | Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with left ventricular pacing and recording (List separately in addition to code for primary procedure) |
93623 | Programmed stimulation and pacing after intravenous drug infusion (List separately in addition to code for primary procedure) |
93650 | Intracardiac catheter ablation of atrioventricular node function, atrioventricular conduction for creation of complete heart block, with or without temporary pacemaker placement |
93653 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia with right atrial pacing and recording and catheter ablation of arrhythmogenic focus, including intracardiac electrophysiologic 3-dimensional mapping, right ventricular pacing and recording, left atrial pacing and recording from coronary sinus or left atrium, and His bundle recording, when performed; with treatment of supraventricular tachycardia by ablation of fast or slow atrioventricular pathway, accessory atrioventricular connection, cavo-tricuspid isthmus or other single atrial focus or source of atrial re-entry |
93654 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia with right atrial pacing and recording and catheter ablation of arrhythmogenic focus, including intracardiac electrophysiologic 3-dimensional mapping, right ventricular pacing and recording, left atrial pacing and recording from coronary sinus or left atrium, and His bundle recording, when performed; with treatment of ventricular tachycardia or focus of ventricular ectopy including left ventricular pacing and recording, when performed |
93655 | Intracardiac catheter ablation of a discrete mechanism of arrhythmia which is distinct from the primary ablated mechanism, including repeat diagnostic maneuvers, to treat a spontaneous or induced arrhythmia (List separately in addition to code for primary procedure) |
93656 | Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia including left or right atrial pacing/recording, and intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac electrophysiologic 3-dimensional mapping, intracardiac echocardiography with imaging supervision and interpretation, right ventricular pacing/recording, and His bundle recording, when performed |
93657 | Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure) |
93662 | Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure) |
93745 | Initial set-up and programming by a physician or other qualified health care professional of wearable cardioverter-defibrillator includes initial programming of system, establishing baseline electronic ECG, transmission of data to data repository, patient instruction in wearing system and patient reporting of problems or events |
C1721 | Cardioverter-defibrillator, dual chamber |
C1722 | Cardioverter-defibrillator, single chamber |
C1730 | Catheter, electrophysiology, diagnostic, other than 3D mapping, 19 or fewer electrodes |
C1731 | Catheter, electrophysiology, diagnostic, other than 3D mapping, 20 or more electrodes |
C1732 | Catheter, electrophysiology, diagnostic/ablation, 3D or vector mapping |
C1733 | Catheter, electrophysiology, diagnostic/ablation, other than 3D or vector mapping other than cool-tip |
C1753 | Catheter, intravascular ultrasound |
C1759 | Catheter, intracardiac echocardiography |
C1760 | Closure device, vascular |
C1764 | Event recorder, cardiac |
C1768 | Graft, vascular |
C1777 | Lead, cardioverter-defibrillator, endocardial single coil |
C1779 | Lead, pacemaker, transvenous VDD single pass |
C1785 | Pacemaker, dual chamber, rate-responsive |
C1786 | Pacemaker, single chamber, rate-responsive |
C1876 | Stent, noncoated/noncovered, with delivery system |
C1877 | Stent, noncoated/noncovered, without delivery system |
C1882 | Cardioverter-defibrillator, other than single or dual chamber |
C1895 | Lead, cardioverter-defibrillator, endocardial dual coil |
C1896 | Lead, cardioverter-defibrillator, other than endocardial dual coil |
C1898 | Lead, pacemaker, other than transvenous VDD single pass |
C1899 | Lead, pacemaker/cardioverter-defibrillator combination |
C1900 | Lead, left ventricular coronary venous system |
C2617 | Stent, noncoronary, temporary, without delivery system |
C2619 | Pacemaker, dual chamber, nonrate-responsive |
C2620 | Pacemaker, single chamber, nonrate-responsive |
C2621 | Pacemaker, other than single or dual chamber |
C2623 | Catheter, transluminal angioplasty, drug-coated, nonlaser |
C2624 | Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components |
C2630 | Catheter, electrophysiology, diagnostic/ablation, other than 3D or vector mapping, cool-tip |
C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
C9601 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery |
C9602 | Percutaneous transluminal coronary atherectomy with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch |
C9603 | Percutaneous transluminal coronary atherectomy with drug eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery |
C9604 | Percutaneous transluminal revascularization of or through coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel |
C9605 | Percutaneous transluminal revascularization of or through coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft |
C9606 | Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, single vessel |
C9607 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel |
C9608 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, each additional coronary artery, coronary artery branch, or bypass graft |
E0616 | Implantable cardiac event recorder with memory, activator, and programmer |
G0278 | Iliac and/or femoral artery angiography, nonselective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography |
G0448 | Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing |
K0606 | Automatic external defibrillator, with integrated electrocardiogram analysis, garment type |
K0607 | Replacement battery for automated external defibrillator, garment type only, each |
K0608 | Replacement garment for use with automated external defibrillator, each |
K0609 | Replacement electrodes for use with automated external defibrillator, garment type only, each |
S2205 | Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft |
S2206 | Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts |
S2207 | Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft |
S2208 | Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft |
S2209 | Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft |
______________________________________________________________________________________
Wellcare
CMS Prior Authorization Change Summary: Effective January 1, 2026
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will implement new prior authorization (PA) response time requirements for all providers.
- Standard prior authorization requests will be completed within 7 calendar days, with a possible extension up to 14 calendar days under certain circumstances.
- Expedited/Urgent prior authorization requests will be completed within the lesser of 72 hours -OR- the current BD turnaround time.
With shorter response times for supporting clinical information requests, all necessary clinical information should be submitted at the time of the authorization request.
Additional Information
- Complete clinicals include Diagnosis, History and Current Condition, Treatment Plan and Interventions, and Relevant Diagnostic Tests.
- Response times can be lessened if all information is submitted with the authorization request.
- Missing clinical information may lead to a denial due to inadequate supporting records.
- Submitting prior authorization requests via the secure Availity portal allows for faster review.
Centene clinical policies and criteria can be found at Availity.
If you have any questions, please contact your provider relations representative.
Wellcare Medical Clinical Policy updates
Please visit the Wellcare website for upcoming Wellcare policy updates.
______________________________________________________________________________________
Training/Education
Multi-payer Collaborative Primary Care Provider Learning Cohort
Join the Final Meeting of the MPC Primary Care Provider Learning Cohort 2
The Washington Multi-Payer Collaborative (MPC) invites representatives from primary care practices to participate in the final session of the MPC Primary Care Provider Learning Cohort 2
When: Tuesday, December 9, from 9:00–11:00 AM PST (virtual).
This meeting offers an opportunity for peer-to-peer learning and for practices to share insights directly with payers and policymakers, ensuring that primary care perspectives remain central to these important discussions.
Discussion will focus on community health workers and preventive care. The target audience is primary care physicians, physician assistants, nurse practitioners, registered nurses, and practice administrators.
Participation in this meeting may be eligible for Continuing Medical Education (CME) credit. Participants will understand value proposition and effective practices related to preventive care and community health workers. Participants will apply this knowledge and their experience to identify opportunities for collective action to take advantage of opportunities to improve in these areas and barriers to success.
- Accreditation: The School of Medicine, Oregon Health & Science University (OHSU), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- Credit: Oregon Health & Science University School of Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To join or ask questions, please reach out to Nicole Thompson, thonicol@ohsu.edu.
For more information about the Washington Multi-payer please visit:
Primary Care Transformation | Washington State Health Care Authority
Autism Center of Excellence (COE) Certification Training
CENTER OF EXCELLENCE (COE) certification allows eligible providers to diagnose autism spectrum disorder for pediatric patients with Washington State Medicaid insurance. Live ZOOM Training: Friday, Dec 5, 2025, 8:30-4:30 pm Eligible COE providers: MD, DO, ARNP, ND and PA-C. Note: Neurologists, psychiatrists, licensed psychologists and developmental behavioral pediatricians are recognized as COEs without attending the training. SLPs, OTs, mental health clinicians, care coordinators, school personnel, administrators and other partners in evaluating and /or caring for autistic children and youth are also welcome.
Presenters:
• Gary Stobbe, MD: Attending Neurologist, Seattle Children’s Autism Center; Director, UW Medicine Adult Autism Clinic
• Jim Mancini, MS, CCC-SLP: Speech-Language Pathologist, University of WA, Director of WA INCLUDE and Project ECHO WA
• Jen Gerdts, PhD: Psychologist
• And additional multi-disciplinary experts
The free COE training focuses on current research and thinking regarding the evaluation, treatment and continuing care for autistic children and youth and their families including:
• Getting support from your administration
• Screening, evaluation and diagnosis
• Differential diagnosis and co-occurring diagnoses
• Diagnostic evaluation models
• Applied Behavioral Analysis (ABA) and other Interventions
• Documentation, billing codes and orders
• Lived experience perspectives from autistic and family advocates
• Advice from current community COE clinicians
• Resources for families
• ECHO Autism Washington and other follow up support
• Q & A and connect with regional partners
Completion of a free online 3 credit CME 1 course -- “Autism Identification and Collaborative Care” from the American Academy of Pediatrics/ Pedialink is required before the training. Details can be found on the Medical Home website found below.
To register online, visit: https://medicalhome.org/coe
Evolent training sessions
Evolent training sessions will be scheduled for several dates beginning in December. For additional program details and to register for training, please visit the Evolent resource page. For program changes effective January 1.
Self Neglect Summit
Join the 2025 Self-Neglect Summit, a vital gathering of professionals, advocates, and community leaders committed to ethically navigating the complexities of self-neglect. This year’s theme: Ethics of Intervention-Empowering Human Services in Cases of Self-Neglect. The focus is real-world strategies, compassionate care, and interdisciplinary collaboration.
Keynote: We are thrilled to welcome Chris Dubble, a nationally recognized expert in ethics and social work, whose insights will challenge and inspire us to think critically and act compassionately.
Panel Discussion: We will have a conversation with leaders from Mobile Integrated Health Programs, exploring innovative, community-based approaches to supporting individuals experiencing self-neglect.
Featured Presentation: Hear directly from the Designated Crisis Responder (DCR) of Olympic Health and Recovery Services, sharing frontline perspectives and ethical decision-making in crisis intervention.
When: Tuesday December 2
8:30am-12:00pm
Trauma 101 What is Trauma? This training answers this question by defining trauma, how trauma affects children, and what caregivers can do to assist children. The presentation will heighten the caregiver’s awareness of children’s cues so they will know what to expect and how to respond when a child experiences trauma triggers. Dec 8, 2025 01:00 PM Register.
Supporting LGBTQIA+ Youth in Foster Care This curriculum was developed through Amara with input from Coordinated Care and guidance from many community organizations. This training is for caregivers and professionals who work in the child welfare setting. Dec 10, 2025 01:00 PM Register.
Suicide Prevention in Youth: Provides an overview of the topic of suicide, signs and symptoms in youth, and how professionals and caregivers should respond in times of crisis. The training will dive into the rates of youth suicide, risk factors, and proactive steps to take for prevention. Will include a discussion on self-harm and social media. This training has many resources to utilize, as well as being useful for concerns of suicidal ideation in adults as well. Dec 1, 2025 01:00 – 03:00pm Register.
Trauma Informed Care: Connections & Healing: Children (like adults) often define themselves through their connections. If they have been moved often, pulled from those they are connected and attached to, is it any wonder they feel and act fragmented from their lives? This in turn potentially opens the door for further trauma and disconnection. This Trauma Informed training discusses ways for caregivers and professionals to help a child develop connections, practical tips on communicating about trauma and help the child build a strength based understanding of their personal story. Dec 2, 2025 05:30pm Register.
Coping with Holiday Stress with Youth: All of us can feel stressed around the holidays. This stress can be amplified by feelings of grief and loss for youth in foster care, kinship and early adoption. This training will help participants identify holiday concerns that children in new homes feel, create a healthy environment for the holidays, and how to help youth, caregivers & professionals cope. Dec 18, 2025 12:30pm Register.
______________________________________________________________________________________
Pharmacy Updates
January 1, 2026 Preferred Drug List Changes
Effective January 1, 2026, the drugs listed below will be non-preferred, non-covered, or will require a prior authorization (PA). Impacted members will be notified prior to this change.
Drug Class | Drug Name | Preferred Alternative(s) |
ANTICOAGULANTS- Blood Thinners: Thrombin Inhibitors | Pradaxa CAPS (dabigatran etexilate mesylate) | dabigatran etexilate mesylate CAPS (generic for Pradaxa) |
THYROID AGENTS - Drugs to Regulate Thyroid Hormones: Thyroid Hormones | Adthyza TABS, Armour Thyroid TABS, Niva Thyroid TABS, NP Thyroid TABS, Renthyroid TABS, and Thyroid TABS | Levothyroxine Sodium TABS and Liothyronine Sodium TABS |
ANTINEOPLASTICS AND ADJUNCTIVE THERAPIES- Drugs to Treat Cancer: Antimetabolites | Purixan SUSP 2000 MG/100ML (mercaptopurine) | Mercaptopurine SUSP 2000 MG/100MG (generic for Purixan)
|
Pharmacy Clinical Policy Updates
The following pharmacy policies have been updated or will be new. These policies will be posted on the policy site, including a description of revisions here.
Policy Number | Policy Title | Effective Date | Line of Business
|
WA.PHAR.66 | Antibiotics Anti-Infective Agents- Oral rifaximin (XIFAXAN) | 10/01/2025 | Medicaid |
WA.PHAR.72 | Hematopoietic Agents Granulocyte Colony Stimulating Factors (G-CSF) | 10/01/2025 | Medicaid |
WA.PHAR.106 | Migraine Agents- CGRP Receptor Antagonists | 10/01/2025 | Medicaid |
HIM.PA.139 | Opioid Analgesics* | 11/01/2025 | Ambetter |
HIM.PA.156 | Evolocumab (Repatha) | 11/01/2025 | Ambetter |
HIM.PA.161 | Human Growth Hormone (Somapacitan, Somatrogon, Somatropin) | 11/01/2025 | Ambetter |
HIM.PA.166 | Evinacumab-dgnb (Evkeeza) | 11/01/2025 | Ambetter |
CP.PHAR.59 | Zoledronic Acid (Reclast) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.98 | Ruxolitinib (Jakafi, Opzelura) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.103 | Immune Globulins | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.184 | Aflibercept (Eylea, Eylea HD), Aflibercept-yszy (Opuviz), Aflibercept-jbvf (Yesafili), Aflibercept-mrbb (Ahzantive), Aflibercept-abzv (Enzeevu), Aflibercept-ayyh (Pavblu)
| 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.216 | Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi)
| 11/01/2025 | Ambetter |
CP.PHAR.287 | Obeticholic Acid (Ocaliva) | 11/01/2025 | Ambetter |
CP.PHAR.290 | Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.322 | Pembrolizumab (Keytruda) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.367 | Letermovir (Prevymis) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.371 | Triamcinolone ER Injection (Zilretta) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.410 | Bortezomib (Velcade) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.464 | Selumetinib (Koselugo) | 11/01/2025 | Ambetter & Medicaid |
CP.PHAR.465 | Teprotumumab (Tepezza) | 11/01/2025 | Ambetter |
CP.PHAR.483
| Lisocabtagene Maraleucel (Breyanzi) | 11/01/2025 | Ambetter |
CP.PHAR.592 | Beremagene geperpavec-svdt (Vyjuvek) | 11/01/2025 | Ambetter |
CP.PMN.04 | Non-Calcium Phosphate Binders | 11/01/2025 | Ambetter & Medicaid |
CP.PMN.99 | Prasterone (Intrarosa) | 11/01/2025 | Ambetter & Medicaid |
CP.PMN.100 | Risedronate (Actonel, Atelvia) | 11/01/2025 | Ambetter |
CP.PMN.104 | Tasimelteon (Hetlioz, Hetlioz LQ) | 11/01/2025 | Ambetter |
CP.PMN.212 | Bedaquiline (Sirturo) | 11/01/2025 | Ambetter & Medicaid |
CP.PMN.218 | Lasmiditan (Reyvow) | 11/01/2025 | Ambetter & Medicaid |
CP.PMN.223 | Rifabutin (Mycobutin) | 11/01/2025 | Ambetter & Medicaid |
CP.PMN.258 | Conjugated Estrogens/Bazedoxifene (Duavee) | 11/01/2025 | Ambetter & Medicaid |
WA.PHAR.49.AB | IL4 IL 13 Inhibitors | 12/01/2025 | Medicaid |
WA.PHAR.49.AH | CAM-JAK Inhibitors | 12/01/2025 | Medicaid |
WA.PHAR.50 | Growth Hormone Agents | 12/01/2025 | Medicaid |
WA.PHAR.122 | Antidiabetics- GLP-1 Agonists | 12/01/2025 | Medicaid |
CP.PCH.09
| Penicillamine (Cuprimine)
| 12/01/2025 | Ambetter |
CP.PCH.28
| Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex)
| 12/01/2025 | Ambetter |
CP.PCH.32
| Dapsone (Aczone Gel)
| 12/01/2025 | Ambetter |
CP.PCH.53
| Leuprolide Acetate (Eligard, Fensolvi, Lupron Depot, Lupron Depot-Ped), Leuprolide Mesylate (Camcevi, Camcevi ETM)
| 12/01/2025 | Ambetter |
CP.PCH.43
| Colonoscopy Preparation Products
| 12/01/2025 | Ambetter |
CP.PCH.44 | Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep)
| 12/01/2025 | Ambetter |
CP.PCH.57 | Abrocitinib (Cibinqo) | 12/01/2025 (new policy) | Ambetter |
CP.PCH.58 | Lebrikizumab (Ebglyss) | 12/01/2025 (new policy) | Ambetter |
CP.PCH.59 | Nemolizumab-ilto (Nemluvio) | 12/01/2025 (new policy) | Ambetter |
CP.PCH.60 | Tralokinumab-ldrm (Adbry) | 12/01/2025 (new policy) | Ambetter |
CP.PHAR.05
| Hyaluronate Derivatives
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.43
| Sapropterin Dihydrochloride (Kuvan, Javygtor) | 12/01/2025 | Ambetter |
CP.PHAR.58 | Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost), Denosumab-dssb (Ospomyv, Xbryk), Denosumab-bmwo | 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.79
| Lapatinib (Tykerb)
| 12/01/2025 | Ambetter |
CP.PHAR.93
| Bevacizumab (Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.116 | Pomalidomide (Pomalyst) | 12/01/2025 | Ambetter |
CP.PHAR.129
| Venetoclax (Venclexta)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.130
| Avatrombopag (Doptelet, Doptelet Sprinkle)
| 12/01/2025 | Ambetter |
CP.PHAR.131
| Infertility and Fertility Preservation
| 12/01/2025 | Ambetter |
CP.PHAR.132
| Nitisinone (Harliku, Nityr, Orfadin)
| 12/01/2025 | Ambetter |
CP.PHAR.133
| Idelalisib (Zydelig)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.134
| Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.136
| Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.137
| Ivosidenib (Tibsovo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.138
| Lenvatinib (Lenvima)
| 12/01/2025 | Ambetter |
CP.PHAR.139
| Mogamulizumab-kpkc (Poteligeo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.140
| Pegvaliase-pqpz (Palynziq)
| 12/01/2025 | Ambetter |
CP.PHAR.141
| Ribavirin
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.142
| Adefovir (Hepsera)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.143
| Betaine (Cystadane)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.149
| Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax/Ozobax DS)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.151
| Levoleucovorin (Fusilev, Khapzory)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.170
| Degarelix Acetate (Firmagon)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.171
| Goserelin Acetate (Zoladex)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.175
| Triptorelin Pamoate (Trelstar, Triptodur)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.173
| Leuprolide Acetate (Eligard, Fensolvi, Lupron Depot, Lupron Depot-Ped), Leuprolide Mesylate (Camcevi, Camcevi ETM)
| 12/01/2025 | Medicaid |
CP.PHAR.201
| Belatacept (Nulojix)
| 12/01/2025 | Ambetter |
CP.PHAR.246
| Canakinumab (Ilaris)
| 12/01/2025 | Ambetter |
CP.PHAR.259
| Natalizumab (Tysabri), Natalizumab-sztn (Tyruko)
| 12/01/2025 | Ambetter |
CP.PHAR.260
| Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab/Hyaluronidase (Rituxan Hycela)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.293
| Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.304
| Irinotecan Liposome (Onivyde)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.305
| Obinutuzumab (Gazyva)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.307
| Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.308
| Elotuzumab (Empliciti)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.309
| Carfilzomib (Kyprolis)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.311
| Belinostat (Beleodaq)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.313
| Pralatrexate (Folotyn)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.314
| Romidepsin (Istodax)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.317
| Cetuximab (Erbitux)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.318
| Eribulin Mesylate (Halaven)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.320
| Necitumumab (Portrazza)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.321
| Panitumumab (Vectibix)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.324
| Temsirolimus (Torisel)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.325
| Ziv-Aflibercept (Zaltrap)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.328
| Asfotase Alfa (Strensiq)
| 12/01/2025 | Ambetter |
CP.PHAR.332
| Pasireotide (Signifor, Signifor LAR)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.334
| Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara)
| 12/01/2025 | Ambetter |
CP.PHAR.352
| Daunorubicin/Cytarabine (Vyxeos)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.353
| Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.354
| Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando)
| 12/01/2025 | Ambetter |
CP.PHAR.355
| Abemaciclib (Verzenio)
| 12/01/2025 | Ambetter |
CP.PHAR.358
| Gemtuzumab Ozogamicin (Mylotarg)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.359
| Inotuzumab Ozogamicin (Besponsa) | 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.363
| Enasidenib (Idhifa)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.365
| Neratinib (Nerlynx)
| 12/01/2025 | Ambetter |
CP.PHAR.368
| Pemetrexed (Alimta, Pemfexy)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.387
| Azacitidine (Onureg, Vidaza)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.389 | Pegvisomant (Somavert)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.390
| Cholic Acid (Cholbam)
| 12/01/2025 | Ambetter |
CP.PHAR.391
| Lanreotide (Somatuline Depot and Unbranded)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.393
| Leucovorin Injection
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.397
| Cemiplimab-rwlc (Libtayo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.399
| Dacomitinib (Vizimpro)
| 12/01/2025 | Ambetter |
CP.PHAR.400
| Duvelisib (Copiktra)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.434
| Bremelanotide (Vyleesi)
| 12/01/2025 | Medicaid |
CP.PHAR.435
| Darolutamide (Nubeqa)
| 12/01/2025 | Ambetter |
CP.PHAR.436
| Pexidartinib (Turalio)
| 12/01/2025 | Ambetter |
CP.PHAR.437
| Thioguanine (Tabloid)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.438
| Trientine (Cuvrior, Syprine)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.439
| Valrubicin (Valstar)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.441
| Entrectinib (Rozlytrek)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.442
| Fedratinib (Inrebic)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.446
| Flibanserin (Addyi)
| 12/01/2025 | Medicaid |
CP.PHAR.461
| Nadofaragene Firadenovec-vncg (Adstiladrin)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.462
| Ozanimod (Zeposia)
| 12/01/2025 | Ambetter |
CP.PHAR.490 | Rimegepant (Nurtec ODT)
| 12/01/2025 | Ambetter |
CP.PHAR.506
| Antithymocyte Globulin (Atgam, Thymoglobulin)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.507
| Lomustine (Gleostine)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.508
| Tafasitamab-cxix (Monjuvi)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.509
| Triheptanoin (Dojolvi)
| 12/01/2025 | Ambetter |
CP.PHAR.510 | Arimoclomol (Miplyffa) | 12/01/2025 | Ambetter |
CP.PHAR.513
| Plasminogen, Human-tvmh (Ryplazim)
| 12/01/2025 | Ambetter |
CP.PHAR.551
| Anifrolumab-fnia (Saphnelo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.552
| Belumosudil (Rezurock)
| 12/01/2025 | Ambetter |
CP.PHAR.553
| Belzutifan (Welireg)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.554
| Chlorambucil (Leukeran)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.556
| Elivaldogene Autotemcel (Skysona)
| 12/01/2025 | Ambetter |
CP.PHAR.558
| Mitapivat (Pyrukynd)
| 12/01/2025 | Ambetter |
CP.PHAR.559
| Mobocertinib (Exkivity)
| 12/01/2025 | Ambetter |
CP.PHAR.561
| Tisotumab Vedotin-tftv (Tivdak)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.566
| Atogepant (Qulipta)
| 12/01/2025 | Ambetter |
CP.PHAR.591
| Tofersen (Qalsody)
| 12/01/2025 | Ambetter |
CP.PHAR.594
| Donanemab (Kisunla)
| 12/01/2025 | Ambetter |
CP.PHAR.596
| Lecanemab-irmb (Leqembi)
| 12/01/2025 | Ambetter |
CP.PHAR.597
| Leniolisib (Joenja)
| 12/01/2025 | Ambetter |
CP.PHAR.598
| Lifileucel (Amtagvi)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.622
| Lenacapavir (Sunlenca, Yeztugo)
| 12/01/2025 | Ambetter |
CP.PHAR.630
| Zavegepant (Zavzpret)
| 12/01/2025 | Ambetter |
CP.PHAR.641
| Avacincaptad Pegol (Izervay)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.643
| Fidanacogene Elaparvovec-dzkt (Beqvez)
| 12/01/2025 | Ambetter |
CP.PHAR.645
| Niraparib and Abiraterone Acetate (Akeega)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.646
| Quizartinib (Vanflyta)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.647 | Resmetirom (Rezdiffra) | 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.648
| Rozanolixizumab-noli (Rystiggo)
| 12/01/2025 | Ambetter |
CP.PHAR.649
| Talquetamab-tgvs (Talvey)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.651
| DaxibotulinumtoxinA-lanm (Daxxify)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.652
| Elranatamab-bcmm (Elrexfio)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.653
| Melphalan (Hepzato)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.654
| Momelotinib (Ojjaara)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.655
| Motixafortide (Aphexda)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.673 | Garadacimab-gxii (Andembry) | 12/01/2025 | Ambetter |
CP.PHAR.678
| Afamitresgene Autoleucel (Tecelra)
| 12/01/2025 | Ambetter |
CP.PHAR.682
| Levacetylleucine (Aqneursa)
| 12/01/2025 | Ambetter |
CP.PHAR.691
| Axatilimab-csfr (Niktimvo)
| 12/01/2025 | Ambetter |
CP.PHAR.692
| Crinecerfont (Crenessity)
| 12/01/2025 | Ambetter |
CP.PHAR.693
| Denileukin Diftitox-cxdl (Lymphir)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.695
| Lazertinib (Lazcluze)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.696
| Palopegteriparatide (Yorvipath)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.697
| Revakinagene Taroretcel-lwey (Encelto)
| 12/01/2025 | Ambetter |
CP.PHAR.698 | Seladelpar (Livdelzi)
| 12/01/2025 | Ambetter |
CP.PHAR.699
| Vorasidenib (Voranigo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.700
| Vanzacaftor/Tezacaftor/Deutivacaftor (Alyftrek)
| 12/01/2025 | Ambetter |
CP.PHAR.701
| Diazoxide Choline (Vykat XR)
| 12/01/2025 | Ambetter |
CP.PHAR.702
| Inavolisib (Itovebi)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.705
| Zolbetuximab-clzb (Vyloy)
| 12/01/2025 | Ambetter & Medicaid |
CP.PHAR.730 | Zopapogene Imadenovec-drba (Papzimeos) | 12/01/2025 | Ambetter |
CP.PHAR.744 | Delgocitinib (Anzupgo) | 12/01/2025 (new policy) | Ambetter |
CP.PHAR.745 | Dordaviprone (Modeyso) | 12/01/2025 (new policy) | Ambetter & Medicaid |
CP.PHAR.750 | Zongertinib (Hernexeos) | 12/01/2025 (new policy) | Ambetter & Medicaid |
CP.PHAR.751 | Rilzabrutinib (Wayrilz) | 12/01/2025 (new policy) | Ambetter |
CP.PHAR.753 | Gemcitabine Intravesical System (Inlexzo) | 12/01/2025 (new policy) | Ambetter & Medicaid |
CP.PHAR.754 | Imlunestrant (Inluriyo) | 12/01/2025 (new policy) | Ambetter & Medicaid |
CP.PHAR.755 | Paltusotide (Palsonify) | 12/01/2025 (new policy) | Ambetter & Medicaid |
CP.PHAR.756 | Remibrutinib (Rhapsido) | 12/01/2025 (new policy) | Ambetter |
CP.PMN.08
| Lidocaine Transdermal (Lidoderm, ZTlido)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.17
| Droxidopa (Northera)
| 12/01/2025 | Medicaid |
CP.PMN.46
| Roflumilast (Daliresp, Zoryve)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.47
| Rifaximin (Xifaxan)
| 12/01/2025 | Ambetter |
CP.PMN.53
| Off-Label Use
| 12/01/2025 | Medicaid |
CP.PMN.54
| Clobazam (Onfi, Sympazan)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.59
| Quantity Limit Override and Dose Optimization | 12/01/2025 | Ambetter |
CP.PMN.95
| Fluticasone Propionate (Xhance)
| 12/01/2025 | Ambetter |
CP.PMN.109
| Suvorexant (Belsomra)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.110 | Crisaborole (Eucrisa) | 12/01/2025 | Ambetter |
CP.PMN.112
| Naldemedine (Symproic)
| 12/01/2025 | Ambetter |
CP.PMN.116
| L-glutamine (Endari)
| 12/01/2025 | Ambetter |
CP.PMN.142 | Lubiprostone (Amitiza) | 12/01/2025 | Ambetter |
CP.PMN.143 | Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.165
| Fluorouracil Cream (Tolak)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.167
| Neomycin/Fluocinolone Cream (Neo-Synalar)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.168
| Ospemifene (Osphena)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.169
| Methylnaltrexone Bromide (Relistor)
| 12/01/2025 | Ambetter |
CP.PMN.170
| Eluxadoline (Viberzi)
| 12/01/2025 | Ambetter |
CP.PMN.172
| Zolpidem Tartrate (Edluar, Zolpimist)
| 12/01/2025 | Medicaid |
CP.PMN.173
| Ramelteon (Rozerem)
| 12/01/2025 | Medicaid |
CP.PMN.174
| Perindopril/Amlodipine (Prestalia)
| 12/01/2025 | Medicaid |
CP.PMN.175
| Doxepin (Silenor)
| 12/01/2025 | Medicaid |
CP.PMN.176
| Amlodipine/Atorvastatin (Caduet)
| 12/01/2025 | Medicaid |
CP.PMN.177
| Glycopyrronium (Qbrexza)
| 12/01/2025 | Medicaid |
CP.PMN.179
| Megestrol Acetate
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.180
| Halobetasol Propionate (Bryhali, Lexette, Ultravate)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.181
| Calcipotriene/Betamethasone Dipropionate Foam (Enstilar)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.182
| Betamethasone Dipropionate Spray (Sernivo)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.184
| Stiripentol (Diacomit)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.185
| Baloxavir Marboxil (Xofluza)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.210
| Acyclovir Buccal Tablet (Sitavig)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.213
| Ferric Maltol (Accrufer)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.214 | Continuous Glucose Monitors | 12/01/2025 | Ambetter |
CP.PMN.215
| Non-Preferred Blood Glucose Monitors/Test Strips
| 12/01/2025 | Medicaid |
CP.PMN.216
| Diazepam (Libervant, Valtoco)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.226
| Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep)
| 12/01/2025 | Medicaid |
CP.PMN.244
| Tazarotene (Arazlo, Fabior, Tazorac)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.249 | Ciprofloxacin/Fluocinolone (Otovel) | 12/01/2025 | Ambetter & Medicaid |
CP.PMN.250
| Colesevelam (Welchol)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.251
| Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi)
| 12/01/2025 | Medicaid |
CP.PMN.252
| Metoclopramide (Gimoti)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.255
| No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update
| 12/01/2025 | Medicaid |
CP.PMN.256
| Nifurtimox (Lampit)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.266 | Finerenone (Kerendia) | 12/01/2025 | Ambetter & Medicaid |
CP.PMN.267 | Levodopa Inhalation Powder (Inbrija) | 12/01/2025 | Ambetter & Medicaid |
CP.PMN.268
| Tenofovir Alafenamide Fumarate (Vemlidy)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.270 | Pilocarpine (Qlosi, Vuity) | 12/01/2025 | Ambetter & Medicaid |
CP.PMN.282
| Ketorolac Nasal Spray (Sprix)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.283
| Tapinarof (Vtama)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.284
| Dextromethorphan/Bupropion (Auvelity)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.286
| Glaucoma Agents
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.291 | Lotilaner (Xdemvy) | 12/01/2025 | Ambetter & Medicaid |
CP.PMN.295
| Semaglutide (Wegovy)
| 12/01/2025 | Ambetter |
CP.PMN.297
| Brivaracetam (Briviact)
| 12/01/2025 | Ambetter & Medicaid |
CP.PMN.298
| Tirzepatide (Zepbound)
| 12/01/2025 | Ambetter |
CP.PMN.302 | Aceclidine (Vizz) | 12/01/2025 (new policy) | Ambetter & Medicaid |
CP.PMN.303 | Brensocatib (Brinsupri) | 12/01/2025 (new policy) | Ambetter & Medicaid |
HIM.PA.03
| Ophthalmic Corticosteroids
| 12/01/2025 | Ambetter |
HIM.PA.09
| Insulin Glargine (Basaglar, Lantus/unbranded Lantus, Rezvoglar, Toujeo/unbranded Toujeo)
| 12/01/2025 | Ambetter |
HIM.PA.17
| Methoxsalen (Uvadex)
| 12/01/2025 | Ambetter |
HIM.PA.20
| Halcinonide (Halog)
| 12/01/2025 | Ambetter |
HIM.PA.33
| No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update
| 12/01/2025 | Ambetter |
HIM.PA.71
| Topical Acne Treatment
| 12/01/2025 | Ambetter |
HIM.PA.87
| Testosterone (Androderm)
| 12/01/2025 | Ambetter |
HIM.PA.103
| Brand Name Override and Non-Formulary Medications
| 12/01/2025 | Ambetter |
HIM.PA.119
| Azelaic Acid (Finacea Topical Gel/Foam)
| 12/01/2025 | Ambetter |
HIM.PA.130
| Naproxen Oral Suspension (Naprosyn)
| 12/01/2025 | Ambetter |
HIM.PA.147
| Doxepin (Silenor, Prudoxin, Zonalon)
| 12/01/2025 | Ambetter |
HIM.PA.152
| Nitazoxanide (Alinia)
| 12/01/2025 | Ambetter |
HIM.PA.154
| Off-Label Drug Use
| 12/01/2025 | Ambetter |
HIM.PA.159
| Prucalopride (Motegrity)
| 12/01/2025 | Ambetter |
HIM.PA.167
| Naloxegol (Movantik)
| 12/01/2025 | Ambetter |
HIM.PA.171
| Insulin detemir (Levemir)
| 12/01/2025 | Ambetter |
HIM.PA.173
| Palbociclib (Ibrance)
| 12/01/2025 | Ambetter |
HIM.PA.176
| Tezepelumab (Tezspire)
| 12/01/2025 | Ambetter |
HIM.PA.SP55
| Uridine Triacetate (Vistogard)
| 12/01/2025 | Ambetter |
HIM.PA.SP60
| Biologic and Non-biologic DMARDs
| 12/01/2025 | Ambetter |
HIM.PA.SP64
| Eptinezumab-jjmr (Vyepti)
| 12/01/2025 | Ambetter |
HIM.PA.SP65
| Erenumab-aooe (Aimovig)
| 12/01/2025 | Ambetter |
HIM.PA.SP66
| Fremanezumab-vfrm (Ajovy)
| 12/01/2025 | Ambetter |
HIM.PA.SP67
| Galcanezumab-gnlm (Emgality)
| 12/01/2025 | Ambetter |
HIM.PA.SP69
| Dupilumab (Dupixent)
| 12/01/2025 | Ambetter |
HIM.PA.SP70
| Benralizumab (Fasenra)
| 12/01/2025 | Ambetter |
WA.CP.PMN.151 | QL of Blood Glucose Test Strips and Lancets Not Receiving Insulin | 12/15/2025 | Medicaid |
WA.PHAR.14 | Second Opinion Network (SON) | 12/15/2025 | Medicaid |
WA.PHAR.126 | Non-Contracted Drugs | 12/15/2025 | Medicaid |
WA.PHAR.129 | Appropriate Use and Safety | 12/15/2025 | Medicaid |
WA.CP.PMN.234 | EPSDT Benefit for Pediatric Members | 01/01/2026 | Medicaid |
CC.PHAR.01 | 72-Hour Supply of Medication | 01/01/2026 | Medicaid |
WA.PHAR.49.AL | Cytokine and CAM Antagonisists- IL-36 inhibitors | 02/01/2026 (new policy) | Medicaid |
WA.PHAR.151 | Oncology Agents- BRAF Kinase Inhibitors- Oral | 02/01/2026 (new policy) | Medicaid |
WA.PHAR.152 | Oncology Agents- Phosphatidylinositol 3-Kinase (P13K) Inhibitors | 02/01/2026 (new policy) | Medicaid |
WA.PHAR.153 | Endocrine and Metabolic Agents- Somatostatic Agents | 02/01/2026 (new policy) | Medicaid |
WA.PHAR.154 | Medical Necessity | 02/01/2026 (new policy) | Medicaid |